Searchable abstracts of presentations at key conferences in endocrinology

ea0090p550 | Adrenal and Cardiovascular Endocrinology | ECE2023

Is there any link between non-classic adrenal hyperplasia (NCAH) and glucose metabolism?

Domagała Bartosz , Gamrat Aleksandra , Skalniak Anna , Przybylik-Mazurek Elwira , Trofimiuk-Muldner Malgorzata , Hubalewska-Dydejczyk Alicja

Introduction: There are data reporting an increased risk of cardiovascular and metabolic complications in patients with NCAH. This is frequently attributed to glucocorticoid (over)use. It seems that long-term exposure to increased androgens concentration may also itself lead to diminished insulin sensitivity and increased risk of prediabetes and diabetes.Aim: The aim of the study was to assess the link between NCAH diagnosis and glucose metabolism distur...

ea0093oc28 | Oral communication 4: Pituitary and Neuroendocrinology | EYES2023

Hepatic Steatosis Index as a non-invasive marker for liver steatosis in patients with endogenous Cushing Syndrome, ERCUSYN Krakow database

Minasyan Mari , Gamrat Aleksandra , Hubalewska-Dydejczyk Alicja , Valassi Elena , Gilis-Januszewska Aleksandra

Introduction: Liver Steatosis (LS) can be one of the metabolic complications of Cushing Syndrome (CS). The data on the impact of cortisol on liver function are very limited, according to one study the prevalence of LS in CS is 20%. However, the frequency seems to be much higher. Hepatic Steatosis Index (HSI) predicts LS based on ALT, AST, BMI, sex and co-existence of diabetes mellitus/impaired glucose intolerance. It can identify candidates for further liver examinations.<...

ea0093p20 | Guided Poster Tour 2: Miscellaneous | EYES2023

Venous thromboembolism in Cushing syndrome – A call for standardized anticoagulation regimen in hypercortisolism

Minasyan Mari , Bryk-Więzania Agata , Gamrat Aleksandra , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Cushing Syndrome (CS) is associated with a 18-fold higher risk of venous thromboembolism (VTE) when compared to the general population with the similar demographic characteristics. Despite numerous studies on hypercoagulability in CS, the unequivocal recommendations regarding timing and dosing of thromboprophylaxis in hypercortisolism are still lacking. We present a case series of patients with CS and VTE, hospitalized in the Endocrinology Department of University Hospital in ...

ea0099p283 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Hepatic steatosis index as a non-invasive marker for liver steatosis in patients with endogenous cushing syndrome, Ercusyn krakow database

Minasyan Mari , Gamrat Aleksandra , Hubalewska-Dydejczyk Alicja , Valassi Elena , Gilis-Januszewska Aleksandra

Introduction: Liver Steatosis(LS) can be one of the metabolic complications of Cushing Syndrome(CS). The data on the impact of cortisol on liver function are very limited, and there is only one study reporting a prevalence of LS of roughly 20%. Hepatic Steatosis Index (HSI) predicts LS based on ALT, AST, BMI, sex and co-existence of diabetes mellitus/impaired glucose intolerance.Objectives: To evaluate the prevalence of LS in patients with CS at the time...

ea0099ep342 | Endocrine-Related Cancer | ECE2024

Heterogeneity of responses of dynamic tests in patients with ectopic cushing’s syndrome (ECS). the half of patients with ECS have an increase in ACTH in the CRH/desmopressin test, nearly 1/3 have complete or some inhibition of cortisol in HDDST

Gamrat Aleksandra , Minasyan Mari , Aleksandra Komisarz-Calik Maria , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: According to the literature, the CRH test has the highest specificity in excluding ECS (ACTH 93.9%, cortisol 89.4%). A combination of the high dose dexamethasone test (HDDST) and CRH/desmopressin test (CRH/desmopressinT) is used to increase the discriminatory capacity in ACTH-dependent CS.Objectives: This study aims to investigate the response to dynamic tests in ECS patients.Methods: 35 consecutive ECS patients were ...

ea0099p311 | Endocrine-Related Cancer | ECE2024

The impact of primary tumor site on clinical manifestation and prognosis of ectopic Cushing’s syndrome (ECS). Do pulmonary neuroendocrine tumors stand out?

Gamrat Aleksandra , Minasyan Mari , Komisarz-Calik Maria Aleksandra , Rzepka Ewelina , Paleń-Tytko Joanna , Opalinska Marta , Hubalewska-Dydejczyk Alicja , Gilis-Januszewska Aleksandra

Introduction: Ectopic Cushing’s syndrome (ECS) is a rare disease with limited and error-prone published data on the epidemiology, clinical presentation and diagnosis of ECS.Objectives: This study aims to examine the clinical course of patients with ECS in relation to the primary tumor localization.Methods: Thirty-five consecutive ECS patients at a tertiary clinical center were analyzed. The clinical, biochemical (including CRH...